Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 17 studies | 28% ± 11% | |
| brain | 17 studies | 42% ± 19% | |
| peripheral blood | 16 studies | 29% ± 11% | |
| eye | 8 studies | 37% ± 15% | |
| intestine | 7 studies | 24% ± 11% | |
| kidney | 6 studies | 22% ± 5% | |
| heart | 5 studies | 29% ± 5% | |
| liver | 5 studies | 34% ± 14% | |
| bone marrow | 4 studies | 26% ± 7% | |
| lymph node | 4 studies | 22% ± 2% | |
| adipose | 4 studies | 49% ± 24% | |
| pancreas | 3 studies | 41% ± 16% | |
| uterus | 3 studies | 35% ± 11% | |
| breast | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 9051.69 | 459 / 459 | 100% | 49.32 | 1118 / 1118 |
| esophagus | 100% | 7509.49 | 1445 / 1445 | 100% | 43.32 | 183 / 183 |
| ovary | 100% | 12570.26 | 180 / 180 | 100% | 45.68 | 430 / 430 |
| uterus | 100% | 14125.77 | 170 / 170 | 100% | 48.72 | 459 / 459 |
| lung | 100% | 8573.40 | 577 / 578 | 100% | 42.53 | 1155 / 1155 |
| prostate | 100% | 9692.01 | 245 / 245 | 100% | 44.19 | 501 / 502 |
| thymus | 100% | 11676.88 | 653 / 653 | 99% | 56.39 | 601 / 605 |
| bladder | 100% | 8682.33 | 21 / 21 | 99% | 40.44 | 500 / 504 |
| brain | 99% | 6512.66 | 2619 / 2642 | 100% | 51.44 | 705 / 705 |
| pancreas | 100% | 4757.10 | 327 / 328 | 99% | 37.43 | 176 / 178 |
| adrenal gland | 100% | 5480.70 | 258 / 258 | 98% | 29.33 | 226 / 230 |
| intestine | 100% | 9253.66 | 966 / 966 | 98% | 36.84 | 517 / 527 |
| stomach | 100% | 6256.75 | 359 / 359 | 97% | 37.52 | 278 / 286 |
| kidney | 100% | 5640.18 | 89 / 89 | 97% | 30.48 | 874 / 901 |
| liver | 99% | 3210.21 | 224 / 226 | 95% | 21.53 | 387 / 406 |
| skin | 100% | 6979.76 | 1808 / 1809 | 92% | 46.21 | 436 / 472 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 47.71 | 29 / 29 |
| spleen | 100% | 8171.13 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 37.42 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 21.76 | 1 / 1 |
| blood vessel | 100% | 10013.96 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 7319.31 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 4917.71 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 4738.95 | 838 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 68% | 18.42 | 54 / 80 |
| peripheral blood | 56% | 3437.94 | 517 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008380 | Biological process | RNA splicing |
| GO_0006397 | Biological process | mRNA processing |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0001530 | Molecular function | lipopolysaccharide binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | ZRANB2 |
| Protein name | Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing) |
| Synonyms | ZNF265 ZIS |
| Description | FUNCTION: Splice factor required for alternative splicing of TRA2B/SFRS10 transcripts. May interfere with constitutive 5'-splice site selection. . |
| Accessions | ENST00000254821.10 [O95218-2] O95218 ENST00000370920.8 [O95218-1] ENST00000611683.1 [O95218-2] |